Daisuke Kubota
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Regulation of nuclear transport of the transcriptional factor REST improves axon regeneration in peripheral nerves.
Journal: Molecular medicine reports
Published: May 21, 2025
Potential Involvement of Myostatin in Smooth Muscle Differentiation in Pleomorphic Leiomyosarcoma.
Journal: International journal of molecular sciences
Published: December 31, 2024
Glycoprotein 130 improves repressor element‑1 silencing transcription factor‑related axon regenerative capacity in peripheral nerves with aging.
Journal: Molecular medicine reports
Published: October 08, 2024
Subtotal Second Toe Transfer for Finger Reconstruction after Malignant Fibroblastic Tumor Resection.
Subtotal Second Toe Transfer for Finger Reconstruction after Malignant Fibroblastic Tumor Resection.
Journal: Journal of hand and microsurgery
Published: June 10, 2024
Non-metastatic hip fractures surgery in patients with active cancer: benefit and risk.
Journal: International orthopaedics
Published: January 15, 2024
NTRK2 expression in gastrointestinal stromal tumors with a special emphasis on the clinicopathological and prognostic impacts.
Journal: Scientific reports
Published: June 26, 2023
Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma.
Journal: Technology in cancer research & treatment
Published: December 08, 2022
A retrospective analysis of the prognosis of Japanese patients with sarcoma brain metastasis.
Journal: Cancer medicine
Published: September 23, 2022
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.
Journal: Discover oncology
Published: March 25, 2022
Molecular and clinicopathological analysis revealed an immuno-checkpoint inhibitor as a potential therapeutic target in a subset of high-grade myxofibrosarcoma.
Journal: Virchows Archiv : an international journal of pathology
Published: February 16, 2022
IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma.
Journal: Discover oncology
Published: October 14, 2021
Last Updated: 09/26/2026